Research Reveals Immune System-Based Therapy Produces Lasting Remissions in Melanoma Patients

A joint study conducted by researchers at Dana-Farber Cancer Institute, Johns Hopkins University and Yale University has identified a cancer drug, which can trigger the immune system to attack tumors and is able to produce lasting remissions and stop the progress of the disease for more than two years in melanoma patients. The study, published online today, March 3, by the iJournal of Clinical Oncology/i, provides the longest-term look so far at how melanoma ...

Read More

You have just read an article categorized health titled Research Reveals Immune System-Based Therapy Produces Lasting Remissions in Melanoma Patients.

Written by: editor - Thursday, March 6, 2014